← FDA Drug Approvals (Drugs@FDA)

QUZYTTIR

NDA · New Drug Application · Sponsor: ESTEVE · Approved 2019-10-04

Drug application

FDA Application #

NDA211415

Application type

New Drug Application

Brand name

QUZYTTIR

Generic name

CETIRIZINE HYDROCHLORIDE

Active ingredients

CETIRIZINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ESTEVE

Manufacturer

TerSera Therapeutics LLC

First approval

2019-10-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown